PEPFAR

This literature review identifies studies examining the impact of the Mexico City Policy, from 2001 to the present, with particular focus on capturing recent studies assessing the policy under the Trump administration.

This KFF summary details global health funding amounts in the FY 2025 House Labor Health and Human Services, Education, and Related Agencies (Labor HHS) appropriations bill and accompanying report.

Includes all of PEPFAR’s multi-year strategies, as well as related documents.

Includes PEPFAR’s original authorizing legislation, as well as each subsequent reauthorization legislation.

The COP/ROP guidance underpins the development of annual plans by both bilateral and regional PEPFAR programs.

This KFF budget summary provides an analysis of global health funding in the FY 2025 House State, Foreign Operations, and Related Programs (SFOPs) Appropriations bill.

This analysis outlines the potential reach of a prominent conservative proposal — widely seen as a blueprint for another Trump administration — that recommends expanding the Mexico City Policy to include virtually all U.S. foreign assistance. It looks at the amount of funding, the number of organizations, the range of foreign assistance sectors, and other variables that could be affected should the proposal be implemented.

This Health Policy 101 chapter outlines the U.S. government’s efforts in global health, which aim to improve health in low- and middle-income countries while supporting U.S. global development, national security, and foreign policy goals. As the largest funder of global health programs worldwide, the U.S. provides bilateral and multilateral support to address major global health areas such as HIV and maternal and child health. Key issues addressed include U.S. global health leadership in a challenging U.S. political and budget environment, helping countries prepare for unexpected health challenges, and sustainability in the context of weak health systems and equity challenges.

With the new omnibus bill, PEPFAR has been reauthorized until March 25, 2025, without the inclusion of any controversial provisions or changes related to abortion, sought by some. Still, while this latest step provides the program with some short-term certainty, including signaling bipartisan support (albeit limited), it marks a significant departure from PEPFAR’s past.

This fact sheet provides an updated overview of federal funding for HIV/AIDS, highlighting key domestic and global HIV/AIDS programs and comparisons over time.